Evidence map›Paper›PMID 26627937›Full record

ArticleFree radical biology & medicine2016

Mechanism of neem limonoids-induced cell death in cancer: Role of oxidative phosphorylation.

Neelu Yadav, Sandeep Kumar, Rahul Kumar, Pragya Srivastava, Leimin Sun, Peter Rapali, Timothy Marlowe, Andrea Schneider, Joseph R Inigo, Jordan O'Malley and 5 more

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploring the role of3 Biotech · 2021
    Review
  5. Bio-selective hormonal breast cancer cytotoxic and antioxidant potencies ofBiotechnology reports (Amsterdam, Netherlands) · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Neelu YadavDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address: neelu.yadav@roswellpark.org.
Sandeep KumarDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Rahul KumarDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Pragya SrivastavaDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Leimin SunDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA; Gastroenterology Department, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou 310016, China.
Peter RapaliDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Timothy MarloweDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Andrea SchneiderDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Joseph R InigoDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Jordan O'MalleyDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Ramesh LondonkarDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Raghu GogadaDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Ajay K ChaudharyDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Nagendra YadavaPioneer Valley Life Sciences Institute, Springfield, MA 01107, USA.
Dhyan ChandraDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. Electronic address: dhyan.chandra@roswellpark.org.
Roswell Park Comprehensive Cancer Center · USPioneer (United States) · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Hsp60 regulation of apoptosis in prostate cancerR01CA160685 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CHANDRA, DHYAN · 2013 to 2018
$1.1M
NCI NIH HHS P30 CA016056NCI NIH HHS P30CA016056NCI NIH HHS R01 CA160685NCI NIH HHS R01CA160685
6 · The paper itself

Abstract

We have previously reported that neem limonoids (neem) induce multiple cancer cell death pathways. Here we dissect the underlying mechanisms of neem-induced apoptotic cell death in cancer. We observed that neem-induced caspase activation does not require Bax/Bak channel-mediated mitochondrial outer membrane permeabilization, permeability transition pore, and mitochondrial fragmentation. Neem enhanced mitochondrial DNA and mitochondrial biomass. While oxidative phosphorylation (OXPHOS) Complex-I activity was decreased, the activities of other OXPHOS complexes including Complex-II and -IV were unaltered. Increased reactive oxygen species (ROS) levels were associated with an increase in mitochondrial biomass and apoptosis upon neem exposure. Complex-I deficiency due to the loss of Ndufa1-encoded MWFE protein inhibited neem-induced caspase activation and apoptosis, but cell death induction was enhanced. Complex II-deficiency due to the loss of succinate dehydrogenase complex subunit C (SDHC) robustly decreased caspase activation, apoptosis, and cell death. Additionally, the ablation of Complexes-I, -III, -IV, and -V together did not inhibit caspase activation. Together, we demonstrate that neem limonoids target OXPHOS system to induce cancer cell death, which does not require upregulation or activation of proapoptotic Bcl-2 family proteins.

Indexed as

Oxidative PhosphorylationApoptosisAzadirachtaCaspasesCyclin-Dependent Kinase Inhibitor p21DNA, MitochondrialDynaminsElectron Transport Complex IGTP PhosphohydrolasesHCT116 CellsHumansLimoninsMicrotubule-Associated ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial ProteinsCaspasesCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNA, MitochondrialDNM1L protein, humanDynaminsElectron Transport Complex IGTP PhosphohydrolasesLimoninsMicrotubule-Associated ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial ProteinsTP53 protein, humanTumor Suppressor Protein p53ApoptosisMitochondrial DNANecroptosisNeemOxidative phosphorylation complexROS

Identifiers

PMID26627937
PMCPMC4734361
OpenAlexW2176928749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.